Value-added
Omega Arastirma conducts Policy Studies for Market Access in order to make a positive contribution to evaluation by explaining the therapeutic area/disease, indication and product more effectively in the licensing, pricing and reimbursement processes.
More Information
Provides consultancy service on the development of alternative study models which will positively support the reimbursement evaluation decisions of innovative drugs, which are in compliance with the regulations, applicable, having proven efficacy, and in which the public and the company can benefit together.
More Information
It provides consultancy service for the determination of reimbursement application strategy in different therapeutic areas, diseases and indications, preparation of the reimbursement file and managing the reimbursement evaluation process.
More Information
The pharmacoeconomic model developed globally is updated with local data and its adaptation for Türkiye and reporting are carried out.
More Information
Focus group studies are carried out with experts consisting of local data supply for model adaptation, prevalence and incidence analysis, patient number analysis and market share analysis.
More Information
Corporate and customized training services are offered to pharmaceutical, medical material and device companies, non-governmental organizations and public institutions.
More Information
Consultancy services are offered in a wide range, from the preparation plan before patent expiry to competition strategies in the generic environment.
More Information
It enables the sector to benefit from digital health technologies by developing configurable platforms for healthcare managers and decision makers and user-friendly database systems with mobile applications for service providers.
More Information
Social Responsibility Programs are designed by Omega Arastirma to accelerate patients' access to innovative medicines.
More Information
It provides consultancy service for the licensing, pricing, reimbursement evaluation and decision-making process, market analysis, evaluation of specific markets, distribution channel strategy, tax regulations, investment incentives and data protection policy.
More Information
Consultancy services are offered in externally funded national and international projects, support to health authorities and capacity building.
More Information